Diamond-Blackfan Anemia 6

Search Trials
Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
Status:
Completed
Last Changed:
Dec 26, 2019
First Changed:
Aug 7, 2013
Disease(s):
Hurler Syndrome
Intervention(s):
Abatacept
Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
Status:
Terminated
Last Changed:
Jul 27, 2017
First Changed:
Mar 22, 2011
Disease(s):
Thalassemia
Intervention(s):
Alefacept
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Status:
Completed
Last Changed:
Sep 24, 2019
First Changed:
Feb 9, 2012
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
fludarabine phosphatemelphalantotal-body irradiationtacrolimusmycophenolate mofetilmethotrexatelaboratory biomarker analysisallogeneic hematopoietic stem cell transplantationperipheral blood stem cell transplantation
Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
Status:
Recruiting
Last Changed:
Jun 24, 2022
First Changed:
Jul 16, 2021
Disease(s):
Bone Marrow Failure Syndrome
Intervention(s):
TreosulfanFludarabine PhosphateTacrolimusMethotrexateLapine T-Lymphocyte Immune GlobulinPeripheral Blood Stem Cell TransplantationAllogeneic Bone Marrow TransplantationQuality-of-Life Assessment
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Status:
Not yet recruiting
Last Changed:
Feb 27, 2020
First Changed:
Sep 23, 2019
Disease(s):
Acute Leukemia
Intervention(s):
alpha beta depletion

Connect. Empower. Inspire.